Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$619M |
| 2 |
Citigroup
C
|
+$457M |
| 3 |
Cimpress
CMPR
|
+$379M |
| 4 |
Broadcom
AVGO
|
+$374M |
| 5 |
Apple
AAPL
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$348M |
| 2 |
Microsoft
MSFT
|
+$331M |
| 3 |
IQVIA
IQV
|
+$243M |
| 4 |
Costco
COST
|
+$193M |
| 5 |
St. Joe Company
JOE
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.21% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.77% |
| 4 | Industrials | 12.77% |
| 5 | Consumer Discretionary | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
F5
FFIV
$22.1B
| $75.2M | 0.05% |
623,533
-124,757
| -17% | -$15.1M |
|
427
Hanover Insurance
THG
$7.63B
| $75M | 0.05% |
773,695
+63,578
| +9% | +$6.05M |
|
|
EV
428
DELISTED
Eaton Vance Corp.
EV
| $75M | 0.05% |
1,518,305
-39,288
| -3% | -$1.88M |
|
|
KYNB
429
Kyntra Bio
KYNB
$28.5M
| $74.7M | 0.05% |
55,549
-963
| -2% | -$1.01M |
|
430
CMS Energy
CMS
$23.1B
| $74.6M | 0.05% |
1,610,745
+307,776
| +24% | +$14.5M |
|
431
WEC Energy
WEC
$37.7B
| $74M | 0.05% |
1,179,467
-20,824
| -2% | -$1.33M |
|
432
Illumina
ILMN
$29.4B
| $73.6M | 0.05% |
379,846
+40,596
| +12% | +$7.56M |
|
|
GWPH
433
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $72.8M | 0.05% |
717,729
+18,194
| +3% | +$1.95M |
|
434
CVS Health
CVS
$137B
| $72.5M | 0.05% |
891,437
+159,671
| +22% | +$12.6M |
|
435
Axalta
AXTA
$7.01B
| $72.3M | 0.05% |
2,501,040
+290,346
| +13% | +$8.78M |
|
436
DaVita
DVA
$15.1B
| $71.3M | 0.05% |
1,201,218
-16,146
| -1% | -$972K |
|
|
OPLN
437
Openlane
OPLN
$4.17B
| $71.2M | 0.05% |
3,940,997
-454,961
| -10% | -$7.51M |
|
438
Banner Corp
BANR
$2.39B
| $71.1M | 0.05% |
1,160,858
-205,576
| -15% | -$11.6M |
|
439
Westlake Corp
WLK
$9.46B
| $70.9M | 0.05% |
853,538
-512,451
| -38% | -$37.6M |
|
|
ABCO
440
DELISTED
Advisory Board Co
ABCO
| $70.9M | 0.05% |
1,321,308
-1,389,694
| -51% | -$74.9M |
|
441
Arista Networks
ANET
$219B
| $70.5M | 0.05% |
5,950,640
+3,728,624
| +168% | +$39M |
|
442
Acadia Healthcare
ACHC
$3.17B
| $70.5M | 0.05% |
1,475,089
-39,792
| -3% | -$1.94M |
|
443
Iron Mountain
IRM
$38.2B
| $70.3M | 0.05% |
1,807,708
-12,934
| -0.7% | -$483K |
|
|
SYNH
444
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $70.3M | 0.05% |
1,343,931
-355,619
| -21% | -$19.8M |
|
445
Melco Resorts & Entertainment
MLCO
$2.1B
| $70.2M | 0.05% |
2,911,978
+790,700
| +37% | +$17.2M |
|
446
Cognex
CGNX
$10.3B
| $70.1M | 0.04% |
1,271,036
-166,806
| -12% | -$8.47M |
|
447
Sun Communities
SUI
$15B
| $70M | 0.04% |
817,168
+10,636
| +1% | +$940K |
|
448
Norfolk Southern
NSC
$78.8B
| $68.9M | 0.04% |
520,895
-162,658
| -24% | -$19.8M |
|
|
NBL
449
DELISTED
Noble Energy, Inc.
NBL
| $68M | 0.04% |
2,399,484
+540,221
| +29% | +$14.2M |
|
450
Edwards Lifesciences
EW
$47.6B
| $67.7M | 0.04% |
1,859,109
+1,708,575
| +1,135% | +$65.2M |
|
Similar funds
Janus Henderson Group's Q3 2017 Portfolio in Review
As of Q3 2017, Janus Henderson Group held 1,386 positions worth $156B, up 5.9% from $147B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q3 2017 filing shows 78 new, 598 increased, 569 reduced and 102 closed positions. Its largest new stake was Medtronic: 7,457,362 shares worth $580M. The largest sale was Reynolds American Inc, an estimated $348M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2017 buy was Medtronic: 7,457,362 shares worth $580M.
- Janus Henderson Group added most to Citigroup in Q3 2017, an estimated $457M increase.
- Janus Henderson Group's biggest Q3 2017 reduction was Microsoft, cutting an estimated $331M.
- Janus Henderson Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $348M.
- Janus Henderson Group's ten largest holdings make up 14% of its $156B portfolio in Q3 2017.
- Janus Henderson Group opened 78 new positions and closed 102 in Q3 2017.
- Janus Henderson Group's portfolio value rose 5.9% quarter-over-quarter to $156B.
Based on Janus Henderson Group's 13F filing for Q3 2017, filed 14 Nov 2017.